Published in
Elsevier, Cell Stem Cell, 6(8), p. 609-612, 2011
DOI: 10.1016/j.stem.2011.05.013
Links
Tools
Hematopoietic Stem Cell Transplantation and Implications for Cell Therapy Reimbursement
Journal article published in 2011 by
Richard T. Maziarz 
,
Dawn Driscoll
,
Dawn Driscoll
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
As costly stem cell treatments progress from experimental concepts toward licensed products and routine procedures, governmental and private payers grapple with shrinking budgets to cover more lives. We describe efforts underway in the US to create mechanisms for reimbursement of cell therapies and discuss other reimbursement-related issues for the stem cell community.